ARTICLE | Finance
Bicycle pedals on
Bicycle to use £20M to move two bicycle-drug conjugates into clinic for cancer
October 20, 2014 7:00 AM UTC
Bicycle Therapeutics Ltd. plans to use a new cash injection to develop its pipeline of bicycle-drug conjugates (BDCs), with the goal of having its first candidate in the clinic for solid tumors by this time next year.
Bicycle secured £20 million ($32.2 million) last week in a tranched series A round from existing investors Atlas Venture; Novartis Venture Fund; SR One; SV Life Sciences; and Astellas Venture Management...